-
Albany Molecular Research, Icagen Announce New Agreement That Combines Both Companies' Assets
Thursday, January 7, 2016 - 12:35pm | 228Read More...Albany Molecular Research, Inc. (NASDAQ: AMRI), a drug discovery, development and manufacturing services company, announced on Thursday it has entered into a new agreement with Icagen. Icagen partners with pharmaceutical and biotechnology companies to offer industry-leading scientific expertise...

